市場調查報告書
商品編碼
1074782
數位病理的全球市場:各類型(獸醫病理學,人體病理學),各產品(軟體,服務),各部署,各終端用戶,各地區分析 - 預測(到2028年)Digital Pathology Market Forecasts to 2028 - Global Analysis By Type (Veterinary Pathology, Human Pathology), Product (Software, Services), Deployement, End User, and By Geography |
全球數位病理的市場規模,2021年為7億6,159萬美金,在預測期間內預計以15.2%的年複合成長率發展,至2028年達到20億5,063萬美元。
本報告提供全球數位病理市場調查,市場的推動因素與阻礙因素,市場機會,COVID-19影響,各類型、各產品、各部署、各用途、各終端用戶、各地區的市場分析,競爭情形,主要企業的簡介等資訊。
According to Stratistics MRC, the Global Digital Pathology Market is accounted for $761.59 million in 2021 and is expected to reach $2050.63 million by 2028 growing at a CAGR of 15.2% during the forecast period. Digital pathology is a computer-enabled, image-based information platform that helps in the management of information generated from digital slides. Digital pathology will facilitate cutting back human error yet manufacturing precise diagnostic leads to a short turnaround. The processes concerned in digital pathology enable to hurry up routine tasks while not reducing the standard of the execution of every task.
Market Dynamics:
Driver:
Technological advancements
Technological advancements in digital pathology help to overcome limitations as these systems provide efficient and effective results for diagnostic tests. Manual interpretation of tissue slides for disease diagnosis purposes is costly and labor extensive that increases error and inconsistency in the diagnostic result and increases the risk of diagnostic failure and impedes the decision-making process. Digital pathology systems can analyze a large array of slides within a short duration without any diagnostic error.
Restraint:
High cost of digital pathology systems
The high cost associated with technologically advanced digital pathology systems is expected to restrain the growth of the digital pathology market. The average cost of the digital pathology systems for telepathology and whole slide imaging can be unaffordable for many low-resource environments in developing countries. Moreover, the digital pathology systems require costly infrastructure such as larger memory to store data, thereby restricting the usage of digital pathology systems this is leading to restraining the growth of the market.
Opportunity:
Introduction of affordable scanners
The development of affordable scanners is expected to offer growth opportunities for players operating in the digital pathology market. Most private medical practices are small businesses and cannot afford expensive digital pathology systems. The introduction of affordable scanners and the propensity of small players to move towards digitization of pathology workflow will encourage its adoption among pathologists with low or limited budgets.
Threat:
Shortage of trained pathologists
Pathologists play a crucial role in performing laboratory tests essential for disease diagnosis. However, there is a gap between the supply and demand of pathologists worldwide. Digital pathology enables medical practitioners to remotely share important information with pathologists beyond geographical boundaries securely and timely. Moreover, advanced technologies, such as AI and machine learning, help pathologists identify diseases faster and help improve their efficacy and efficiency. Thus, the alarming shortage of pathologists is expected to result in the increased utilization of digital pathology for providing remote pathological consultation and services.
The human pathology segment is expected to be the largest during the forecast period
The human pathology segment is estimated to have a lucrative growth owing to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories. With particular support for education, tissue-based research, drug development, and the profession of human pathology across the world, digital pathology is quickly gaining traction as a proven and important technology.
The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period
The pharmaceutical & biotechnology companies segment is anticipated to witness the fastest CAGR growth during the forecast period due to the increasing use of digital pathology for drug discovery studies and drug toxicology testing, the rise in the prevalence of cancer, and the high demand for better treatment options. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.
Region with highest share:
North America is projected to hold the largest market share during the forecast period due to the rise in the number of various types of cancer cases, increasing demand for quality diagnostics, the introduction of favorable reimbursement policies, the presence of key players, and the implementation of favorable initiatives by the governments in the US and Canada.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period owing to the rising penetration of digital imaging in emerging economies, investments in the medical field, and the presence of untapped opportunities. The presence of a large target patient population and booming healthcare industry is encouraging the growth of the regional market.
Key players in the market
Some of the key players profiled in the Digital Pathology Market include XIFIN, Inc., Visiopharm A/S, Sectra AB, PathAI, OptraSCAN, Akoya Biosciences, Leica Biosystems, Koninklijke Philips N.V., Inspirata, Inc., Indica Labs, Huron Digital Pathology, Apollo Enterprise Imaging, Glencoe Software, F. Hoffmann-La Roche Ltd., Corista, Hamamatsu Photonics, Aiforia Technologies Oy, 3DHISTECH and Objective Pathology Services.
Key Developments:
In September 2021, Visiopharm A/S collaborated with Agilent Technologies, Inc. (US) to co-market Visiopharm's portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent's automated pathology staining solutions portfolio.
In May 2021, Sectra AB signed an agreement with Institut Curie which allows the digitization of pathology at Institut Curie. The pathologists in Institut Curie can access cases, digital tools, and AI applications through the Sectra pathology solution.
Types Covered:
Products Covered:
Deployments Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.